Timber Pharmaceuticals LLC (TMBR) Stock Faltering in Aftermarket, Here’s Why
Timber Pharmaceuticals LLC (TMBR), a clinical-stage biopharmaceutical dermatology company, has plummeted 21.25% in aftermarket trading session and consequently, was trading at $0.63 when last checked.